I don't know. We keep blaming it on being in Australia but maybe something behind the curtains is behind all this. I just don't understand how these companies valuation can be so high and we are so low. Does big pharma see something in our science that makes it a very big risk? Bigger than voyager and and so forth. We keep saying wait for efficacy and then they will come but what about all these other companies that have not even a hint of efficacy that are getting billion dollar valuations? Something just isn't right. Maybe big pharma completely discounts TT-034 as commercially viable and is waiting for Tribetarna.
- Forums
- ASX - By Stock
- BLT
- Sanofi Signs Benitec's closest competitor Voyager for $845M
Sanofi Signs Benitec's closest competitor Voyager for $845M, page-5
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online